estherglas.nl
zaadje
Hij heeft een vraag en hij weet dat ik het antwoord niet wil weten. Toen er thuis visite was merkte ik het al eens. Waar ik heel stellig ben over het niet willen weten van statistieken, over cijfe...
#Oncologie is an active hashtag on Bluesky. In the last 30 days, 5 people shared 11 posts with it — around 0 a day. Activity is down 33% versus the previous week, peaking on Aug 26 with 3 posts.
Again I ask #Medsky why they are not using N95s in #oncology. Why are there no HEPA purifiers in lobbies, patient rooms, etc? There is no justification for not using the most effective tools we have to PREVENT airborne infection. There is no scientific, ethical, nor cost related reason not to.
estherglas.nl
zaadje
Hij heeft een vraag en hij weet dat ik het antwoord niet wil weten. Toen er thuis visite was merkte ik het al eens. Waar ik heel stellig ben over het niet willen weten van statistieken, over cijfe...
www.ipharmacenter.com
IASLC 2026 World Conference on Lung Cancer (#WCLC26) | 2026 | iPharmaCenter
Enhertu Becomes First HER2-Targeted Therapy to Beat Standard Care in Frontline Lung Cancer, Extending Time Without Progression by Six MonthsAstraZeneca and Daiichi Sankyo have announced positive resul...
www.ipharmacenter.com
Pharmaceutical Healthcare Deals & Acquisitions - 2026 | iPharmaCenter
GSK Bets $750 Million on Chinese Biotech's Triple-Targeting T Cell Engager for Multiple Myeloma, Marking Second Deal in Two YearsGSK has agreed to pay up to $750 million for global rights to an experi...
www.ipharmacenter.com
FDA Approves Revolution Medicines’ RASONQUE for Metastatic Pancreatic Cancer | iPharmaCenter
The U.S. Food and Drug Administration has approved RASONQUE, also known as daraxonrasib, as a once-daily oral treatment for adults with metastatic pancreatic adenocarcinoma who have received at least ...
www.ipharmacenter.com
European Commission | EMA Drug Approvals | 2026 | iPharmaCenter
European Commission Expands Trodelvy Use in First-Line Metastatic Breast CancerThe European Commission has approved Gilead Sciences’ Trodelvy, also known as sacituzumab govitecan, in combination with ...
www.ipharmacenter.com
NICE Backs Donidalorsen for Hereditary Angioedema and Acalabrutinib for Blood Cancers
The National Institute for Health and Care Excellence has supported several new treatment pathways covering hereditary angioedema, mantle cell lymphoma, and chronic lymphocytic leukaemia.The recommend...
www.ipharmacenter.com
Top 10 Best-Selling Cancer Drugs of 2025
Keytruda $31.7B leads global oncology sales. Full ranking with Darzalex, Opdivo, Tagrisso, Imfinzi, Verzenio, Kisqali, Tecentriq, Ibrance, Perjeta.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.